United States· US:10129-031_50cc21f6-a0d8-b970-e063-6294a90a5c3d

STASIS

A medicinal product containing ferric sulfate, registered in United States by Gingi-Pak a Division of the Belport.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSTASISATC—REGISTER NO.US:10129-031_50cc21f6…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
FERRIC SULFATE
Manufacturer
Gingi-Pak a Division of the Belport
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    10129-031-01
  • ndc11
    10129-031-02

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fc52b1e0-9b9e-409e-8c2e-8a9bf49dbe16
GET /v1/drugs/fc52b1e0-9b9e-409e-8c2e-8a9bf49dbe16?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "DENTAL; PERIODONTAL; SUBGINGIVAL",
  "source": "ndc",
  "strength": "3150",
  "substance": "FERRIC SULFATE",
  "productndc": "10129-031",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/15mL",
  "application_number": null,
  "marketing_category": "UNAPPROVED DRUG OTHER"
}

See everything about ferric sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.